Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Bought by Erste Asset Management GmbH

Erste Asset Management GmbH raised its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) by 45.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,546 shares of the company’s stock after acquiring an additional 5,469 shares during the period. Erste Asset Management GmbH owned approximately 0.06% of Medpace worth $5,928,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of MEDP. Ashton Thomas Securities LLC acquired a new position in Medpace during the third quarter valued at $37,000. GSA Capital Partners LLP purchased a new position in shares of Medpace during the 3rd quarter valued at about $276,000. Baillie Gifford & Co. lifted its holdings in shares of Medpace by 175.6% in the 3rd quarter. Baillie Gifford & Co. now owns 14,876 shares of the company’s stock valued at $4,966,000 after buying an additional 9,478 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in shares of Medpace by 6.3% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 45,473 shares of the company’s stock valued at $15,179,000 after buying an additional 2,675 shares during the period. Finally, KBC Group NV boosted its stake in shares of Medpace by 5.5% in the third quarter. KBC Group NV now owns 1,213 shares of the company’s stock worth $405,000 after buying an additional 63 shares during the last quarter. 77.98% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Robert W. Baird boosted their price target on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Medpace currently has an average rating of “Hold” and an average price target of $381.44.

Medpace Trading Down 2.1 %

NASDAQ:MEDP opened at $317.93 on Friday. The stock has a 50 day moving average of $340.57 and a two-hundred day moving average of $341.84. The firm has a market cap of $9.69 billion, a P/E ratio of 25.17, a price-to-earnings-growth ratio of 3.81 and a beta of 1.47. Medpace Holdings, Inc. has a 12 month low of $302.01 and a 12 month high of $459.77.

Medpace (NASDAQ:MEDP) last posted its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. On average, research analysts forecast that Medpace Holdings, Inc. will post 12.29 earnings per share for the current year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.